AN2 Therapeutics, Inc.
ANTXBiotechnology
$4.69+3.76%As of Oct 29vs prior close
- Market cap
- $177M
- P/E (TTM)
- –
- From 52W high
- −25.32%
- EPS (LTM)
- -$1.07
- Dividend yield
- 0.00%
Nomior Score
56
Emerging BreakoutSpeculativeTop 35% of the scored universe
Growth—
Quality45
Value—
Momentum88
Resilience38